FDA

Indiana could soon join a growing list of states with laws allowing students to carry sunscreen at school.

The Food and Drug Administration classifies sunscreen as an over the counter medication, like painkillers or cold medicine, and that means some school policies require students to have a doctor or parent’s note in order to even bring sunscreen to school.

But Sen. Liz Brown (R-Fort Wayne) says the bill she’s filed for the 2018 session aims to change that for the state.

The FDA has approved a device developed in Indiana that helps reduce opioid withdrawal symptoms. The NSS-2 BRIDGE is a nerve-stimulating device placed behind the ear which sends electrical pulses to the brain.

It’s been shown to reduce severe effects of opioid withdrawal, such as nausea and vomiting. Sen. Jim Merritt (R-Indianapolis) says the technology fills a gap in treatment.

Spot Us / https://www.flickr.com/photos/29792566@N08/

The inspection of a special type of pharmacy in Hamilton County has Indiana experts examining licensing rules for the industry.

When mass-produced drugs don’t work for some people—they might be allergic to a dye in a pill or need a special dosage, for example—compounding pharmacies, which blend together medications, are called to create custom prescriptions.

FDA To Add More Warnings To Opioid Medications

Mar 23, 2016
ep_jhu / https://www.flickr.com/photos/ep_jhu/3308079338

The FDA Tuesday announced required safety labeling changes for immediate release opioid pain medications, to warn both prescribers and patients of the risks of abuse, addiction and overdose.

Immediate release opioids are designed to be taken every four to six hours, as opposed to long-acting products which are taken once or twice a day.

Research shows opioid addiction usually begins with prescription abuse. Earlier this week, Dr. Michael Cozzi of Fort Wayne was arrested for over-prescribing controlled substances.

Kreg Steppe / https://www.flickr.com/photos/spyndle/535493117

Senate lawmakers unanimously approved legislation Tuesday that its sponsor says will give “hope to the hopeless.” 

The Right to Try bill would allow terminally-ill patients to receive experimental drugs as long as they meet three standards.

Sen. Ed Charbonneau (R-Valparaiso), the bill’s sponsor says, first, the medications must have passed through the first of three phases in the FDA’s approval process.

Brandon Smith / Indiana Public Broadcasting

Senate lawmakers say they want to more time to work on a bill allowing terminally ill patients to try experimental drugs before sending the measure to the floor. 

The bill would help 5-year-old Jordan McLinn, who suffers from Duchenne Muscular Dystrophy.  Those afflicted with the fatal disease typically only live to about age 20. 

But Jordan’s mother, Laura McLinn, told a Senate panel that help could be on the way.  As Jordan sat in her lap, she told lawmakers about a new drug being developed to change Jordan’s type of Muscular Dystrophy into a milder version.

Remember trans fats? And the big campaigns to get them out of burgers, fries and all kinds of baked goods?

Well, those campaigns seem to have worked.

Cystic Fibrosis Drug Wins Approval

Feb 1, 2012

The Food and Drug Administration has approved the first drug that can treat the underlying cause of cystic fibrosis.

The drug, known as Kalydeco, works by helping to fix one defect in the protein that causes the disease.

Copyright 2018 NPR. To see more, visit http://www.npr.org/.

DAVID GREENE, HOST:

It's MORNING EDITION, from NPR News. Good morning. I'm David Greene, in for Renee Montagne.

STEVE INSKEEP, HOST: